Captivate Bio will supply all ELAREM™ human platelet lysate product lines for sale in the US and Canada. Captivate Bio, a scientific cell culture solutions provider, today announced it has signed an exclusive distribution agreement with PL BioScience GmbH, a biotech company located in Aachen, Germany, to bring its portfolio of human platelet lysate to markets […]

Transaction will expand BioIVT’s in vitro diagnostic, cell and gene therapy support capabilities Westbury, NY – BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the acquisition of Valley Biomedical Products & Services, Inc. located in Winchester, VA. Founded in 1986, Valley Biomedical provides specialized biological products and services for the […]

Genuity Science Awarded Designation as a 10x Genomics Certified Service Provider in Single Cell Immune Profiling To Support Global BioPharma Companies Leveraging Robust Single-Cell Technologies for Accelerated and Improved Drug Development Genuity Science, a genomics data, analytics and insights organization, today announced its participation with leading life science technology company, 10x Genomics (Nasdaq: TXG) through 10x Genomics’ […]

MARLBOROUGH, Mass. — Akoya Biosciences Inc., (NASDAQ: AKYA), The Spatial Biology Company®, today announced the appointment of diagnostics industry leader Scott Mendel to its board of directors. “I am delighted to join the board of directors of Akoya, a company that has the potential to transform biomarker discovery and clinical research through the application of […]

WELLESLEY, Mass. — Ampersand Capital Partners announced today that it has completed the sale of Nexcelom Bioscience, one of its portfolio companies and a leading provider of automated cell counting solutions, to PerkinElmer for $260 million in cash. Founded in 2003 and headquartered in Lawrence, Massachusetts, Nexcelom is the manufacturer of innovative Cellometer, Cellaca MX, and Celigo image cytometry […]

Broadened agreement includes the development of novel technologies for allogeneic CAR-NK cell expansion Catamaran also secures broad worldwide license to TcBuster™ transposon system for clinical and commercial manufacturing of next generation cell therapies MINNEAPOLIS, MN and CAMBRIDGE, MA – Bio-Techne Corporation (NASDAQ: TECH) and Catamaran Bio today announced an expansion of their collaboration for the […]

We are delighted to have been awarded a grant of up to £320,000 from Innovate UK, the UK’s innovation agency, for the research and development of a 100L bioreactor for stem cell applications. Our existing range Our existing range of patented airlift, single-use bioreactors includes the CellMaker Systems: Regular, Low Flow and Plus – created […]

MatTek Life Sciences, a subsidiary of CELLINK, today announced the acceptance of the EpiDerm™ Phototoxicity Test as part of Test Guideline No. 498 In vitro Phototoxicity: Reconstructed Human Epidermis Phototoxicity Test Method by the Organization of Economic Cooperation and Development (OECD). This effort is very much in line with the Group’s goals to reduce and eventually replace animal […]

Defined recently received a $1.5M in Phase II SBIR award from the National Institutes of Health to develop defined media over the next two years. The funded project aims to make further improvements on HiDef-B8, the company’s flagship product and fully defined medium supplement for human induced pluripotent stem (iPS) cells. First published by the […]